Nutex Health (NUTX) director receives 823 RSUs vesting in 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Saunders Scott J reported acquisition or exercise transactions in this Form 4 filing.

Nutex Health Inc. director Scott J. Saunders received a grant of 823 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Nutex common stock upon vesting. These RSUs vest 100% on April 23, 2027, and will vest on a pro-rata basis if he leaves the company without cause before that date. Following this award, Saunders holds a total of 1,426 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Saunders Scott J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (RSUs)	823	$0.00	--

Holdings After Transaction: Restricted Stock Units (RSUs) — 1,426 shares (Direct, null)

Footnotes (1)

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Key Figures

RSUs granted: 823 RSUs RSUs outstanding after grant: 1,426 RSUs Vesting date: April 23, 2027 +2 more

5 metrics

RSUs granted 823 RSUs Grant to director Scott J. Saunders on April 23, 2026

RSUs outstanding after grant 1,426 RSUs Total RSUs held by Scott J. Saunders following transaction

Vesting date April 23, 2027 100% vesting date for the 823 RSUs

Underlying common stock per RSU 1 share per RSU Each RSU converts into one Nutex common share upon vesting

Exercise/conversion price $0.0000 per RSU No cash exercise price; RSUs settle in shares upon vesting

Key Terms

Restricted Stock Units (RSUs), contingent right, par value, pro-rata basis

4 terms

Restricted Stock Units (RSUs) financial

"The Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

contingent right financial

"Each RSU represents a contingence right to receive one share of the issuer's common stock"

par value financial

"one share of the issuer's common stock, $0.001 par value, upon vesting"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

pro-rata basis financial

"the RSUs shall vest on a pro-rata basis for the actual time in service"

Allocation or distribution that gives each participant a share proportional to their existing ownership, stake or entitlement — like slicing a pie so everyone gets a piece matching how big their original slice was. For investors this matters because it determines how much of new shares, dividends, fees or obligations they receive, helps preserve or change ownership percentages, and directly affects dilution and voting power.

Form 4 Insider Transactions: What Each Field Means →

04/24/2026 - 02:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saunders Scott J

(Last)

(First)

(Middle)

1776 YORKTOWN STREET SUITE 700

C/O NUTEX HEALTH INC.

(Street)

HOUSTON

TEXAS

77056

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSUs)	$0⁽¹⁾	04/23/2026		A		823		04/23/2027⁽²⁾	04/23/2027⁽²⁾	Common Stock	823	$0⁽¹⁾	1,426	D

Explanation of Responses:

1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

2. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

	/s/ Scott J. Saunders	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Nutex Health (NUTX) director Scott Saunders report?

Director Scott J. Saunders reported receiving 823 Restricted Stock Units (RSUs) from Nutex Health as a grant. These RSUs are a form of equity compensation that can convert into common stock if specific vesting conditions are met over time.

When do Scott Saunders’ 823 Nutex Health (NUTX) RSUs vest?

The 823 RSUs granted to Scott Saunders vest 100% on April 23, 2027. Once vested, each RSU entitles him to receive one share of Nutex Health common stock, subject to the terms of the company’s equity compensation plan.

What happens to Scott Saunders’ Nutex Health RSUs if he leaves before vesting?

If Scott Saunders leaves Nutex Health without cause during the vesting period, his 823 RSUs will vest on a pro-rata basis. That means vesting will be adjusted to reflect the actual time he remained in service with the company before departure.

How many Nutex Health (NUTX) RSUs does Scott Saunders hold after this grant?

After receiving the new grant of 823 RSUs, Scott Saunders holds a total of 1,426 RSUs directly. Each RSU represents a contingent right to receive one share of Nutex Health common stock once the applicable vesting conditions are satisfied.

What does each Nutex Health RSU granted to Scott Saunders represent?

Each RSU granted to Scott Saunders represents a contingent right to receive one share of Nutex Health common stock with $0.001 par value. The shares are only delivered after the RSUs vest according to the specified schedule and employment conditions.